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Casper Is a FADD- and Caspase-Related
Inducer of Apoptosis
Hong-Bing Shu, David R. Halpin, the cysteine residue is the structural hallmark of a cas-
pase. This cysteine residue, together with two highlyand David V. Goeddel
conserved residues, corresponding to H237 and G238Tularik, Incorporated
in caspase-1, form the active site of a caspase (WilsonTwo Corporate Drive
et al., 1994; Walker et al., 1994). In addition, many mem-South San Francisco, California 94080
bers of the family are capable of inducing apoptosis
when overexpressed in mammalian cells (Henkart,
1996).
Summary The apoptosis-inducing caspases are usually synthe-
sized as inactive proenzymes that are activated by spe-
Caspases are cysteine proteases that play a central cific proteolytic cleavage. When activated, caspases
role in apoptosis. Caspase-8 may be the first enzyme specifically cleave substrates at sites following an
of the proteolytic cascade activated by the Fas ligand aspartate residue (Henkart, 1996). It has been presumed
and tumor necrosis factor (TNF). Caspase-8 is re- that the caspases exist within hierarchies of auto- and
cruited to Fas and TNF receptor-1 (TNF-R1) through trans-cleavage (Fraser and Evan, 1996). Activation and
interaction of its prodomain with the death effec- amplification of the caspase cascades result in proteo-
tor domain (DED) of the receptor-associating FADD. lytic degradation of specific targets, such as poly(ADP-
Here we describe a novel 55 kDa protein, Casper, that ribose) polymerase, nuclear lamin, and actin (Martin and
has sequence similarity to caspase-8 throughout its Green, 1995). Proteolytic degradation of these targets
length. However, Casper is not a caspase since it lacks may eventually result in cell death.
several conserved amino acids found in all caspases. Many types of stimuli can activate the caspase cas-
Casper interacts with FADD, caspase-8, caspase-3, cades, leading to apoptosis. In recent years, apoptosis
TRAF1, and TRAF2 through distinct domains. When induced by TNF and FasL has received extensive atten-
overexpressed in mammalian cells, Casper potently tion. TNF elicits a broad range of biological effects
induces apoptosis. A C-terminal deletion mutant of (Goeddel et al., 1986; Beutler and Cerami, 1988; Fiers,
Casper inhibits TNF- and Fas-induced cell death, sug- 1991) through two distinct membrane receptors, TNF-
gesting that Casper is involved in these apoptotic R1 (z55 kDa) and TNF-R2 (z75 kDa), which are ex-
pathways. pressed at low levels on most cell types (Loetscher et
al., 1990; Schall et al., 1990; Smith et al., 1990; Fiers,
1991; Tartaglia and Goeddel, 1992). Apoptosis induced
Introduction by TNF is mediated primarily through TNF-R1. The intra-
cellular domain of TNF-R1 contains a ªdeath domainº
Apoptosis is a cell suicide process of sequential bio- of z80 amino acids (aa) that is responsible for signaling
chemical events triggered by a variety of physiological cell death (Tartaglia et al., 1993). A homologous death
and stress stimuli. Several lines of evidence indicate domain is also found in the cytoplasmic region of Fas
that a family of cysteine proteases, or caspases (Alnemri (Itoh and Nagata, 1993) and DR3/Wsl/Apo-3 (Chinnaiyan
et al., 1996), plays a crucial role in the execution of et al., 1996b; Kitson et al., 1996; Marsters et al., 1996),
apoptosis. First, genetic experiments in Caenorhabditis two other members of the TNF receptor family that can
elegans demonstrated that the ced-3 gene is required potently induce apoptosis.
for cell death during hermaphrodite development of the Efforts to understand the early events of TNF- and
nematode (Ellis and Horvitz, 1986). Subsequently, it was Fas-induced apoptosis have been aided by the discov-
found that themammalian interleukin-1b±converting en- eries of several proteins that interact with the intracellu-
zyme (ICE or caspase-1) shares significant homology lar domains of TNF-R1 and Fas. TRADD, a 34 kDa cyto-
with CED-3 and can cause apoptosis when overex- plasmic protein containing a C-terminal death domain,
pressed in mammalian cells (Yuan et al., 1993). interacts with the death domain of TNF-R1 in a ligand-
The second line of evidence for caspase involvement dependent process (Hsu et al., 1995; Hsu et al., 1996a).
in mammalian apoptosis comes from studies showing As observed for TNF-R1, overexpression of TRADD
that caspase inhibitors block apoptosis induced by a causes both apoptosis and activation of NF-kB (Hsu et
wide range of stimuli. One of the best-known caspase al., 1995). The death domain of TRADD also interacts
inhibitors is the protein encoded by the cowpox virus with the death domain of another cytoplasmic protein,
crmA gene (Ray et al., 1992). CrmA inhibits apoptotic FADD (Hsu et al., 1996a). Since a dominant negative
pathways induced by divergent stimuli, including tumor mutant of FADD blocks TNF-R1± and TRADD-induced
necrosis factor (TNF) and FasL, among others (Miura et cell death (Hsu et al., 1996a), the TRADD±FADD interac-
al., 1993; Enari et al., 1995; Hsu et al., 1995; Tewari and tion may be part of the TNF-R1 pathway that signals
Dixit, 1995; Hsu et al., 1996a, 1996b; Henkart, 1996). apoptosis.
Several members of the caspase family have been Fas and FADD also interact directly through their re-
identified (reviewed by Henkart, 1996; nomenclature spective death domains (Boldin et al., 1995; Chinnaiyan
proposed by Alnemri et al., 1996), and they share certain et al., 1995). Although the death domains of TNF-R1,
characteristic features. For example, all known cas- Fas, and TRADD induce apoptosis following overex-
pression in mammalian cells (Tartaglia et al., 1993; Hsupases contain a conserved motif QAC(R/Q)G, in which
Immunity
752
Figure 1. Casper Amino Acid Sequence and
Sequence Comparisons
(A) The predicted amino acid sequence of
Casper is aligned with the sequence of cas-
pase-8. Identical amino acids are shaded.
Caspase-8 amino acids involved in catalysis
are indicated by dots, and the conserved cas-
pase pentapeptide is underlined.
(B) Schematic representation of FADD, Cas-
per, caspase-8, andcaspase-10. Caspercon-
tains two DED modules and a protease-like
domain. The conserved motifs HG and QAC
(R/Q)G of caspases are lacking in Casper.
(C) Phylogenetic analysis of the DED modules
of FADD, Casper, caspase-8and caspase-10.
The numbers in parentheses refer to the
N-terminal (1) and C-terminal (2) DED modules.
(D) Sequence alignments of DED modules.
The DED modules of FADD, Casper, caspase-8
and caspase-10 are classified into two groups
according to their similarity, determined by
phylogenetic analysis. Sequences are aligned
within each groups. Identical amino acids in
each groups are shaded. Consensus amino
acids between the two groups are also indi-
cated.
(E) Sequence alignment of aa 13±176 of Cas-
per with the protein encoded by the MC159L
gene of molluscum contagiosum virus sub-type 1, the hypothetical protein E8 of equine herpesvirus 2, and the open reading frame K13 protein
of Kaposi's sarcoma±associated herpesvirus. Amino acids of the virus proteins identical to that of Casper are shaded.
et al., 1995; Itoh and Nagata, 1993; Hsu et al., 1996b), domain potently induces apoptosis, whereas a deletion
mutant lacking 45 C-terminal aa inhibits TNF- and Fas-overexpression of the C-terminal death domain of FADD
inhibits TNF- and Fas-induced cell death (Chinnaiyan et induced apoptosis, suggesting that Casper may play a
role in cell death pathways activated by TNF and Fas.al., 1996a; Hsu et al., 1996a). The N-terminal domain of
FADD, termed death effector domain (DED), induces
apoptosis after overexpression, suggesting that the Results
DED of FADD may activate a downstream cell death
signaling component (Chinnaiyan et al., 1996a; Hsu et Identification of Casper
TRADD and FADD interact when overexpressed in yeastal., 1996a).
Recently, three groups identified a cysteine protease, and mammalian systems (Hsu et al., 1996a), and a domi-
nant negative mutant of FADD blocks TNF-inducedwhich they named Mch5, MACH, and FLICE, respec-
tively (Boldin et al., 1996; Fernandes-Alnemri et al., 1996; apoptosis (Hsu et al., 1996a; Chinnaiyan et al., 1996a).
However, we have been unable to detect FADD in theMuzio et al., 1996). The unique structure of this protein,
which is now called caspase-8, suggests that it may endogenous TNF-R1 signaling complex (Shu etal., 1996;
unpublished data). This observation implies the possibil-represent the missing link between FADD and the basic
cell death machinery. The N-terminal domain of cas- ity that a FADD-like molecule, rather than FADD itself,
may be a physiological component of the cell deathpase-8 contains two DED-like modules through which
it interacts with FADD (Boldin et al., 1996; Muzio et al., pathway activated by TNF. To identify potential FADD-
related genes, we searched a public database of human1996). The C-terminal domain of caspase-8 is homolo-
gous to members of the caspase family and has protease expressed sequence tags (ESTs). Two ESTs encoding
two distinct peptides were identified, each of which hasactivity toward most known caspases and poly (ADP-
ribose) polymerase (Fernandes-Alnemri et al., 1996; z30% sequence identity with the DED of FADD. Subse-
quent cDNA cloning and sequence analysis demon-Muzio et al., 1996; Srinivasulaet al., 1996). These studies
suggest that caspase-8 may function at the apex of the strated that the two ESTs represent different fragments
of the same gene. The longest cDNA clones obtainedcaspase cascade activated by Fas. Currently, it is not
clear how caspase-8 itself is activated following Fas had an z2.1 kb insert and an open reading frame capa-
ble of encoding a 480 aa protein (Figure 1). We haveactivation.
In this study we have identified a cDNA encoding a designed this protein Casper (for caspase-eight±related
protein).protein we term Casper (caspase-eight±related protein),
which is structurally related to caspase-8. Casper con- Casper has significant sequence similarity to the re-
cently cloned caspase-8 (Boldin et al., 1996; Fernandes-tains two DED-like modules and a protease-like domain.
Despite its high sequence similarity to caspase-8, Casper Alnemri et al., 1996; Muzio et al., 1996) throughout its
length (Figure 1A). It contains two DED-like modules atdoes not contain the conserved motifs that are hallmarks
of caspases. Casper interacts with FADD, caspase-8, its N-terminus, each of which shares z25% sequence
identity with the DEDs of FADD, caspase-8 and cas-caspase-3, TRAF1, and TRAF2 through distinct domains.
Overexpression of Casper or its C-terminal protease-like pase-10 (Fernandes-Alnemri et al., 1996) (Figures 1B±
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(Figure 1 continued from previous page)
1D). The C-terminal 270 aa are z25% identical to the of approximately 1.4, 2.4, 3.8, 6.0, and 9.5 kb. Its expres-
sion is relatively high in skeletal muscle, pancreas, andC-terminal protease domain of the 479 aa caspase-8.
Importantly, the conserved motifs, QACR(Q)G and HG, heart, but was undetectable in the brain (Figure 2A).
To determine whether Casper protein is present underwhich are involved in catalysis and are present in all
identified caspases, are not found in Casper (Figures physiologic conditions, U937 cell lysates were immuno-
precipitated with either a preimmune serum or a poly-1A and 1B), suggesting that Casper is not a cysteine
protease. We also obtained alternatively spliced cDNAs clonal antibody directed against a Casper-derived pep-
tide (aa 160±192). The immunoprecipitating proteinsthat encode truncated forms of Casper and have stop
codons after aa 202 and aa 435. were then detected by Western blot analysis using an
antibody derived against a different Casper peptide (aaInterestingly, a blast search indicated that the DED
modules of Casper are most homologous to three hypo- 215±249). This antibody detected specific bands at z55
and z28 kDa (Figure2B). The size of the z55 kDa proteinthetical viral proteins: the protein product (241 aa) en-
coded by the MC159L gene of molluscum contagiosum is consistent with the predicted molecular weight of full-
length Casper. The z28 kDa protein probably corre-virus subtype 1 (Senkevich et al., 1996), the hypothetical
protein E8 (171 aa) of equine herpesvirus 2 (Telford et sponds to a proteolytic fragment or an alternatively
spliced variant of Casper.al., 1995), and the open reading frame K13 protein (139
aa) of Kaposi's sarcoma-associated herpesvirus (Russo
et al., 1996). These virus proteins have z35% sequence Induction of Apoptosis by Casper
and Its Protease-like Domainidentity with the DED modules of Casper (Figure 1E),
but less than 20% sequence identity with corresponding Since Casper is structurally related to both FADD and
caspase-8, we examined whether Casper is involveddomains of caspase-8, caspase-10, and FADD.
Northern blot analysis suggests that the human Cas- in signaling pathways leading to apoptosis. Using an
established assay (Hsu et al., 1995; 1996a; 1996b), weper gene is expressed as several different transcripts
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Figure 2. Expression of Casper
(A) Northern blot analysis of Casper mRNA in human tissues.
(B) Western blot analysis of Casper protein in U937 cells. Lysates of U937 cells (z1 3 108) were immunoprecipitated with either a preimmune
serum control or the Casper peptide I polyclonal antibody against Casper. Immunoprecipitating proteins were detected with the Casper
peptide II antibody. Ig-H, immunoglobulin heavy chain.
found that Casper overexpression in HeLa cells induced The cowpox virus protein CrmA is a specific caspase
inhibitor that can block apoptosis induced by TRADD,apoptosis (Table 1). Analysis of deletion mutants indi-
cated that the protease-like domain of Casper (aa 192± FADD, and caspase-8 (Tewari and Dixit, 1995; Hsu et
al., 1995, 1996a). CrmA also protects against Casper-480) was necessary and sufficient to induce apoptosis
and was relatively more potent than full-length Casper. induced apoptosis (Table 1), suggesting that Casper
activates a caspase cascade leading to apoptosis.In contrast, caspase-8 is more potent than its protease
domain (aa 217±479) in inducing apoptosis (Table 1). The Although Casper is related to caspase-8 throughout
its length, it does not contain the conserved QACCasper deletion mutants encoding aa 1±96, 192±435,
370±480, and the naturally spliced form aa 1±435 did (R/Q)G motif present inall known caspases. The position
corresponding to the C360 in caspase-8 is a tyrosinenot cause significant cell death in these assays. Interest-
ingly, when overexpressed, the naturally spliced variant residue in Casper. To determine whether the Y360 is
involved in cell killing by Casper, we mutated this resi-of Casper, encoding aa 1±202, had weak apoptosis-
inducing acitivity, similar to that observed for aa 1±198 due to phenylalanine in Casper(192±480), the deletion
mutant that is a potentactivator of apoptosis when over-of caspase-8 (Table 1).
expressed. We found that Casper(192±480Y/F) had sig-
nificantly weaker apoptotic activity compared to its
Table 1. Cell Death Induced by Casper Overexpression wild-type counterpart (Table 1), suggesting that Y360
Number of Blue Cells per Well contributes to Casper's apoptosis-inducing activity.
Expression Vector Control 1CrmA
A Deletion Mutant of Casper BlockspRK5 384 6 5 395 6 8
Casper 71 6 1 340 6 19 TNF- and Fas-Induced Apoptosis
Casper(1±435) 338 6 4 356 6 10 Full-length Casper can induce apoptosis in mammalian
Casper(1±202) 175 6 7 357 6 13 cells, whereas Casper(1±435) does not. To determine
Casper(1±96) 291 6 10 328 6 3
whether Casper might be involved in Fas or TNF signal-Casper(78±480) 87 6 9 346 6 6
ing, we investigated the effect of Casper(1±435) on TNF-Casper(192±480) 34 6 4 339 6 26
and Fas-mediated apoptosis. When Casper(1±435) wasCasper(192±480Y/F) 140 6 18 340 6 20
Casper(370±480) 362 6 12 352 6 11 expressed in HeLa cells, itbehaved as a dominant nega-
Casper(192±435) 333 6 8 331 6 14 tive mutant by inhibiting both TNF- and anti-Fas±
caspase-8 1 6 1 311 6 7 induced apoptosis (Figure 3A).
caspase-8(1±198) 164 6 12 362 6 22
Since TRADD and FADD are downstream death sig-caspase-8(1±436) 310 6 6 345 6 5
naling proteins of TNF-R1 and Fas, we determinedcaspase-8(217±479) 22 6 2 325 6 18
whether Casper(1±435) could inhibit apoptosis inducedTRADD 33 6 5 320 6 8
FADD 81 6 4 342 6 13 by these proteins. Expression vectors for TRADD or
FADD was cotransfected with an expression vector forHeLa cells were transfected with 2 mg of the indicated expression
Casper(1±435). Consistent with its ability to inhibit anti-vector, 0.25 mg of pCMV-b-gal, and 2 mg of pRK control vector or
2 mg of crmA vector. Transfected cells were identified by staining Fas± and TNF-induced apoptosis, Casper(1±435) po-
with X-gal. Data (6 SD) are shown as the number of blue cells per tently inhibited FADD- and TRADD-induced apoptosis
each of two wells. One of at least three representative experiments (Figure 3B). In parallel experiments, a similar deletion
is shown.
mutant (aa 1±436) of caspase-8 also functioned as an
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Figure 3. Functional Analysis of Casper in
Mammalian Cells
(A) A dominant negative mutant of Casper (aa
1±435) blocks anti-Fas± and TNF-induced cell
death. HtTA cells were transfected with 2 mg
of pRK5 control vector or Casper(1±435) ex-
pression vector, together with 0.25 mg of
CMV-b-gal vector. Twenty-four hours after
transfection, cells were left untreated or were
treated with 100 ng/ml TNF or 250 ng/ml anti-
Fas antibody (Panvera) for 12 hr (in the pres-
ence of 10 mg/ml cycloheximide). Cells were
then fixed and stained with X-gal, and surviv-
ing b-gal±positive cells were counted under
a microscope. Numbers shown are the aver-
age of two wells of a representative exper-
iment.
(B) Inhibition of TRADD- and FADD-induced cell death by Casper(1±435). HtTA cells were transfected with 2 mg of expression vectors for
FADD, TRADD, or control vector pRK5, together with 2 mg of pRK5 control or expression vectors for aa 1±435 of Casper or aa 1±436 of
caspase-8, as indicated. pCMV-b-gal vector, 0.25 mg, was added to each transfection. Cells were fixed and stained with X-gal 24 hr after
transfection. The survived b-gal±positive cells were counted under a microscope. Numbers shown are the average of two wells of a representa-
tive experiment.
inhibitor of FADD- and TRADD-induced apoptosis (Fig- not interact with FADD (Figure 4A). Deletion mutants
Casper(1±96) (data not shown) and Casper(78±480) (Fig-ure 3B). These data suggest that Casper may be a com-
ponentof theTNF- and Fas-induced celldeath pathways ure 4A), which contain either the first or second DED,
interacted with FADD weakly. Casper did not interactthat functions downstream of the death domain±
containing proteins. with the death domain proteins TRADD or RIP (data not
shown).
To test whether Casper can be recruited to the FasCasper Interacts with Distinct Signaling Proteins
To elucidate the signaling pathway(s) involving Casper, signaling complex, we transfected293 cells with expres-
sion vectors for Fas, FADD, and Casper. Cell extractswe searched for Casper-interacting proteins using the
yeast two-hybrid system. Several proteins were identi- were immunoprecipitated with an antibody against the
extracellular domain of Fas, and coimmunoprecipitatingfied that specifically interacted with Casper, including
FADD, caspase-8, caspase-10, TRAF1, and TRAF2 (Ta- proteins were detected by immunoblotting analysis (Fig-
ure 4B). Fas did not directly interact with Casper inble 2). Each of these interactions was confirmed in mam-
malian cells (see below). this assay. However, Casper was recruited to Fas when
FADD was coexpressed (Figure 4B). A parallel experi-
ment confirmed earlier observations (Muzio et al., 1996;Casper Interacts with FADD
and Is Recruited to Fas Boldin et al., 1996) that caspase-8 is recruited to Fas
through FADD (Figure 4C).Since Casper and FADD interact in yeast two-hybrid
assays, we tested whether they also interact in mam-
malian cells. Casper or various Casper deletion mutants Casper Interacts with Caspase-8
through Distinct Domainswere coexpressed with FADD in human 293 cells. Coim-
munoprecipitation analysis indicated that the interaction To test whether Casper interacts with caspase-8, 293
cells were transfected with expression vectors for Flag-between Casper and FADD is comparable to that be-
tween caspase-8 and FADD (Figure 4A). The two DED- tagged Casper and Myc-tagged caspase-8. Cell lysates
were immunoprecipitated with an anti-Flag antibodylike modules of Casper are required and sufficient for
its interaction with FADD, presumably through the DED and coimmunoprecipitating proteins were analyzed by
immunoblotting with an anti-Myc antibody. This analysisof FADD, as indicated by yeast two-hybrid assays (data
not shown). The protease-like domain of Casper did showed that Casper interacts with caspase-8 (Figure
Table 2. Yeast Two-Hybrid Screening of Casper-Interacting Proteins
Clones Specific cDNAs
Bait cDNA Library Screened Obtained (Number)
Casper(1±215) B cell 2.6 3 106 FADD (4)
caspase-10 (2)
Peripheral lymph node 2.5 3 106 caspase-8 (4)
Casper(192±480) B cell 6.0 3 106 TRAF1 (3)
TRAF2 (3)
Fetal liver stromal 6 3 105 TRAF2 (3)
Yeast two-hybrid screening was performed using the indicated baits and cDNA libraries following established procedures (Rothe et al., 1994;
Hsu et al., 1995).
His1 and b-gal1 clones were sequenced, and their identities were determined by blast searches of the Genbank database.
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5A). The N-terminal DED modules and the C-terminal
protease-like domain of Casper can independently inter-
act with caspase-8 (Figure 5A). Interestingly, the C-ter-
minal 91 aa of Casper is sufficient to immunoprecipitate
caspase-8 (Figure 5A). Caspase-8 can also interact with
itself and with FADD. Under the same conditions, Cas-
pase-8 does not interact with TRADD (Figure 5A). These
data indicate that Casper and caspase-8 can interact
through distinct domains.
Since Casper can form a complex with caspase-8, we
asked whether these two proteins can act collabora-
tively in inducing apoptosis. To test this, we examined
the apoptosis-inducing activity of Casper(192±480) and
caspase-8(217±479) separately and together in HeLa
cells. At all doses tested, equivalent amounts of the two
expression plasmids together induced apoptosis more
potently than either of them alone (Figure 5B).
CrmA Interacts with Caspase-8 but Not Casper
or Caspase-3
CrmA can block cell death induced by TNF, Fas, and
their signaling proteins TRADD and FADD (Tewari et al.,
1995; Enari et al., 1995; Hsu et al., 1995; 1996a; 1996b;
Figure 4. Casper Interacts with FADD and is Recruited to Fas Chinnaiyan et al., 1996a). In vitro interactions between
(A) Casper interacts with FADD. 293 cells were cotransfected with CrmA and activated caspase-1 (Komiyama et al., 1994)
expression vectors for FADD and Flag-tagged Casper, various Cas- and caspase-3 (Tewari et al., 1995) have also been re-
per deletion mutants, or caspase-8. crmA vector was expressed to
ported. Since CrmA also inhibits apoptosis induced byinhibit celldeath. Cell lysates were immunoprecipitated with an anti-
both Casper and caspase-8, we examined whetherFlag antibody, and coimmunoprecipitating proteins were analyzed
CrmA interacts with either protein in mammalian cells.by Western blotting using an anti-FADD antibody. Positions of the
molecular weight standards (in kilodaltons) are shown. In coimmunoprecipitation experiments, neither Casper
(B and C) FADD recruits Casper and caspase-8 to Fas. 293 cells nor any of its various deletion mutants interacted with
were transfected with expression vectors for Flag-tagged Casper CrmA. Caspase-3 also did not interact with CrmA in this
(B) or caspase-8 (C), together with expression vectors for Fas and
assay. However, caspase-8 coprecipitated with CrmAAU1-tagged FADD. CrmA vector was expressed to inhibit cell death.
(Figure 6). The protease domain of caspase-8 (aa 217±Cell lysates were immunoprecipitated (IP) with a rabbit polyclonal
479) interacts with CrmA much more weakly than doesanti-Fas antibody. Immunoprecipitates were analysed by Western
blotting with an anti-Flag antibody.Positions of themolecular weight the full-length caspase-8 (data not shown). These data
standards (in kilodaltons) are shown. suggest that the most upstream target of CrmA in the
Fas- and TNF-induced apoptosis pathways might be
Figure 5. Physical and Functional Interaction
Between Casper and Caspase-8
(A) Casper interacts with caspase-8 through
distinct domains. 293 cells were transfected
with an expression vector for Myc-tagged
caspase-8, together with various Flag-tagged
expression vectors for the indicated proteins.
CrmA was coexpressed to inhibit cell death.
Cell lysates were immunoprecipitated (IP)
with an anti-Flag antibody or mouse immuno-
globulin G control. Immunoprecipitates were
anayzed by Western blotting with an anti-Myc
antibody. Positions of the molecular weight
standards (in kilodaltons) are shown. Ig-H,
immunoglobulin heavy chain.
(B) Simultaneous expression of the protease-
like domain of Casper and the protease do-
main of caspase-8 leads to enhanced apop-
tosis. HeLa cells were transfected with
indicated amounts of vectors for the prote-
ase-like domain of Casper or the protease
domain of caspse-8 or both together, and cell
death assays were performed as described
above.
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7B). Thus, activation of caspase-3 by Casper in mamma-
lian cells is probably indirect, whereas caspase-8 can
directly process caspase-3 to its active form.
Casper Interacts with Caspase-3
To examine how Casper overexpression leads to cas-
pase-3 activation, we tested whether the two proteins
could physically interact. Expression vectors for various
forms of Casper or caspase-8 (Flag-tagged) were co-
Figure 6. CrmA Interacts with Caspase-8 transfected with an expression vector for caspase-3.
293 cells were transfected with the Myc-tagged crmA vector and Transfected cell lysates were immunoprecipitated with
various Flag-tagged expression vectors as indicated. Transfected
an anti-Flag antibody, and coimmunoprecipitating cas-cell lysates were immunoprecipitated with an anti-Flag antibody.
pase-3 was detected by immunoblotting analysis. CasperImunoprecipitating Myc-CrmA was detected by Western blotting
interacts strongly with caspase-3, and the protease-likewith an anti-Myc antibody. Positions of molecular weight standards
(in kilodaltons) are shown. domain of Casper is sufficient for this interaction (Figure
8A). Interestingly, Casper(192±480Y/F), which is less po-
tent in inducing apoptosis than its wild-type counterpart
(Figure 3A), interacts more weakly with caspase-3 (Fig-caspase-8, and that CrmA might inhibit Casper-induced
ure 8A). In these experiments, neither caspase-8 nor itsapoptosis by blocking caspase-8 activation.
protease domain interacted with caspase-3 (Figure 8A).
Although the protease domain of caspase-8 does notCasper Indirectly Induces Caspase-3 Activity
interact with caspase-3, it can form a complex withSince caspase-3 may be a component of Fas- and TNF-
caspase-3 in the presence of the protease-like domainR1±induced apoptosis pathways (Fernandes-Alnemri et
of Casper (Figure 8B). This result suggests that the pro-al., 1994; Enari et al., 1995; Tewari et al., 1995; Enari et
tease-like domain of Casper can recruit caspase-3 toal., 1996; Nagata, 1996), and since Casper may be an
the protease domain of caspase-8.upstream component of these pathways, we examined
whether Casper can activate caspase-3. We examined
the protease-like domain of Casper since it induces Casper Is Proteolytically Processed
in Mammalian Cellsapoptosis more potently than does full-length Casper,
and since the in vitro±translated protease domain of In our various transfection experiments, we found that
Casper was proteolytically processed. When N-termi-caspase-8 but not full-length caspase-8 can enzymati-
cally activate caspase-3 (Boldin et al., 1996; Fernandes- nally Flag-tagged Casper was overexpressed in 293
cells and lysates were analyzed by immunoblotting withAlnemri et al., 1996; Srinivasula et al., 1996). Lysates
from 293 cellsexpressing either Casper(192±480) or cas- anti-Flag antibody, an N-terminal fragment of z43 kDa
was observed. Casper(78±480) and Casper(192±480)pase-8(217±479) were able toprocess invitro±translated
35S-labeled caspase-3 precursor to its signature z17 were also cleaved, and the resulting N-terminal frag-
ments were aprroximately 34 kDa and 20 kDa in size, re-kDa fragment (Figure 7A). This result suggests that both
the protease-like domain of Casper and the protease spectively (Figure 9A). To detect the processed C-terminal
fragment, we constructed a C-terminally Flag-taggeddomain of caspase-8 can induce a signaling pathway
leading to caspase-3 activation in mammalian cells. Casper vector. However, C-terminally tagged Casper
was not processed (data not shown), suggesting that aTo test for direct processing of caspase-3, we mixed
in vitro±translated Casper(192±480) or caspase-8(217± free C-terminus may be required for Casper processing.
Casper(192±480Y/F) was only weakly processed in479) with 35S-labeled caspase-3. In vitro±translated cas-
pase-8(217±479) was able to process caspase-3, whereas comparison to Casper(192±480) (Figure 9A). This finding
is consistent with our earlier observation that Casper(192±in vitro±translated Casper(192±480) could not (Figure
Figure 7. Casper Indirectly Activates Cas-
pase-3
(A) Overexpression of the protease-like do-
main of Casper or the protease domain of
caspase-8 leads to activation of caspase-3.
293 cells were transfected with the indicated
vectors. Ten-microliter aliquots of transfected
cell lysates were mixed with 2 ml of purified
35S-labeled caspase-3 precursor, and the
mixtures were incubated at 308C for 1.5 hr.
Caspase-3 processing was analyzed by SDS-
PAGE and autoradiography. Positions of the
molecular weight standards (in kilodaltons)
are shown.
(B) Casper does not directly process cas-
pase-3. The protease activity assay was performed as above, except that in vitro translated proteins, rather than transfected cell lysates were
used to cleave caspase-3 precursor. Positions of molecular weight standards (in kilodaltons) are shown.
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for Casper, together with expression vectors for TRAF1,
TRAF2, TRAF3, and various TRAF2 deletion mutants.
Coimmunoprecipitation experiments showed that Cas-
per interacts specifically with TRAF1 and TRAF2, but
not with TRAF3 (Figure 10A). Furthermore, the TRAF-N
domain of TRAF2 was required to bind to Casper (Figure
10A). In similar experiments, we found that TRAF1 and
TRAF2 interact with the protease-like domain but not
the N-terminal region of Casper (Figure 10B).
TRAF2 interacts with several signaling proteins, in-
cluding members of the TRAF family, c-IAP1, c-IAP2,
TRADD, TNF-R2, I-TRAF, and A20 (Rothe et al., 1994,
1995; Hsu et al., 1996a; Song et al., 1996). Among these
TRAF2-interacting proteins, only c-IAP1 and c-IAP2 in-
teract with the TRAF-N domain of TRAF2, whereas the
other proteins interact with the TRAF-C domain. Since
Casper interacts with the TRAF-N domain of TRAF2, we
examined whether Casper can compete with c-IAP1 for
Figure 8. Interaction of Casper with Caspase-3
binding to TRAF2. 293 cells were transfected with ex-
(A) Casper associates with caspase-3. 293 cells were transfected
pression vectors for hemagglutinin (HA)±tagged TRAF2with Myc-tagged caspase-3 vector and various Flag-tagged expres-
and Myc-tagged c-IAP1, together with increasingsion vectors as indicated. Cell lysates were immunoprecipitated
amounts of expression vector for Casper. Coimmuno-with an anti-Flag antibody. Coimmunoprecipitating caspase-3 was
detected by a monoclonal anti-caspase-3 antibody. Positions of the precipitation analysis showed that binding of c-IAP1 to
molecular weight standards (in kilodaltons) are shown. TRAF2 was diminished by increasing Casper expression
(B) Casper(192±480) recruits caspase-3 to activated caspase-8. 293 levels (Figure 10C). Consistent with this observation,
cells were transfected with various combinations of expression vec-
Casper and cIAP-1 do not simultaneously bind to TRAF2tors as indicated. Transfected cell lysates were immunoprecipitated
when overexpressed in 293 cells (data not shown).with mouse immunoglobulin G control or an anti-Flag antibody.
Since Casper and TRADD interact with different do-Coimmunoprecipitating caspase-3 protein was detected with a
monoclonal antibody against caspase-3. Positions of molecular mains of TRAF2, we examined whether TRADD, TRAF2,
weight standards (in kilodaltons) are shown. and Casper can form a complex.Cotransfectionand coim-
munoprecipitation experiments indicate TRADD and Cas-
per cannot simultaneously bind to TRAF2 (data not
480Y/F) is less potent than Casper(192±480) and interacts shown).Furthermore,Casper wasnot recruited to the TNF-
more weakly with caspase-3. Casper(1±435), Casper(192± R1 complex by the addition of TRADD, FADD, and TRAF2,
435), and Casper(370±480), which do not induce apop- either individually or combined (data not shown).
tosis, were not processed, although aa 1±435 and aa 192±
435 contain the putative cleavage site (Figure 9A).
Since the size of the processed N-terminal fragment Discussion
of Casper(78±480) was only slightly larger than that of
nonprocessed Casper(192±480), we reasoned that the In this report we describe the identification and charac-
processing site should occur soon after position 366 terization of Casper, a novel protein with substantial
(the size difference between aa 78±480 and aa 192±480 structural similarity to caspase-8. Like caspase-8, Cas-
is 114 aa). In that region, there are two asparatate resi- per contains two DED-like modules at its N-terminus
dues, at positions 369 and 376, which we mutated to and extensive homology to caspases at its C-terminus.
alanine or asparagine, respectively. Transient transfec- Casper is not a protease and lacks the conserved
tion experiments showed that the D376N mutation abol- QAC(R/Q)G motif, which is a hallmark of caspases. How-
ished the processing activity of Casper, while D369A ever, Casper induces cell death when overexpressed in
mutation had no effect (Figure 9B), suggesting Casper mammalian cells, and its apoptotic activity maps to the
is processed after D376. To determine whether the pro- C-terminal protease-like domain. The N-terminal DED-
cessing of Casper is required for its apoptotic activtiy, containing region of Casper is a weak inducer of cell
we expressed these point mutants in HeLa cells. Both death when overexpressed, similar to the corresponding
mutants potently induced cell death (Figure 9C), demon- region of caspase-8. It is possible that the interaction
strating that the processing of Casper is not required of overexpressed DED-like modules partially mimics the
for its cell killing activity. mechanism by which FADD is able to activate the cell
death pathway.
A Casper deletion mutant lacking 45 C-terminal aaCasper Interacts with TRAF1 and TRAF2
In yeast two-hybrid screening experiments using aa blocks both the TNF and Fas cell death pathways. Cas-
per(1±435) also inhibits TRADD- and FADD-induced192±480 (the protease-like domain) of Casper as bait, we
identified both TRAF1 and TRAF2 (see above), signaling apoptosis pathways. Therefore, Casper may be a com-
ponent of Fas- and TNF-induced cell death pathwaysproteins previously shown to be associated with signal-
ing complexes for both TNF-R1 and TNF-R2 (Rothe et that functions downstream of the death domain pro-
teins. Alternatively, this mutant may bind to FADD andal., 1994; Hsu et al., 1996a; Shu et al., 1996). To test
whether Casper interacts with TRAFs in mammalian prevent recruitment of caspase-8 to the receptor com-
plexes. Since Casper(1±435) occurs as a natural splicecells, 293 cells were transfected with expression vectors
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Figure 9. Casper Processing
(A) Proteolytical processing of Casper in
mammalian cells. 293 cells were transfected
with expression vectors for Flag-tagged Cas-
per and various mutants as indicated, with
(1) or without (-) CrmA expression. Sixteen
hours after transfection, cells were lysed, and
the lysates were analyzedby Western blotting
with an anti-Flag antibody. Positions of the
molecular weight standards (in kilodaltons)
are shown.
(B) Mutation analysis of potential processing
site(s) of Casper. Expression vectors pRK7-
Flag-Casper (D369A, with a D-to-A mutation
at position 369) and pRK7-Flag-Casper
(D376N, with a D-to-N mutation at position
376) were transfected into 293 cells. Sixteen
hours after transfection, cells were lysed, and
the lysates were analyzedby Westernblotting
with anti-Flag antibody. Positions of the mo-
lecular weight standards (in kilodaltons) are
shown.
(C) Induction of apoptosis by Casper and its
point mutants. Cell death assays were per-
formed as describedabove using the indicted
vectors.
variant of Casper, alternative splicing of Casper may it postulates that the first enzyme of the caspase cas-
cade is activated by a nonenzymatic regulator, whichprovide a mechanism to regulate apoptosis triggered
by Fas, TNF-R1, and other cell death pathways. may provide for a more easily controlled cell death appa-
ratus.Casper is similar to caspase-8 in that it interacts with
FADD and can be recruited to Fas via FADD. Several Interestingly, the DED modules of Casper have z35%
sequence identity with viral proteins encoded by ge-lines of evidence suggest that Casper may function as
a coactivator of caspase-8-induced cell death. First, two nomes of molluscum contagiosum virus subtype 1,equine
herpesvirus 2, and Kaposi's sarcoma±associated herpes-distinct domains of Casper can interact with caspase-8.
Second, CrmA, which can inhibit cell death induced by virus. In contrast, the DED modules of caspase-8, cas-
pase-10, and FADD are much less homologous to theseboth Casper and caspase-8, physically interacts only
with caspase-8. This is consistent with the hypothesis viral proteins, suggesting that the DED modules of Cas-
per may be the cellular counterpart of these viral pro-that Casper-induced apoptosis may be mediated by
caspase-8. Third, caspase-3 and caspase-8, which do teins. Since the DED modules of Casper can inhibit
apoptosis induced by Fas and TNF, the viral proteinsnot directly interact with each other, can simultaneously
associate with Casper. Therefore, it is possible that Cas- may antagonize apoptosis by mimicking this function.
This may provide a mechanism for enhancing survivalper may recruit the caspase-3 precusor to the vicinity
of caspase-8, where it can be cleaved to its active form. and replication of these viruses in mammalian cells.
CrmA interacts strongly with full-length caspase-8Consistent with this hypothesis, the protease-like do-
main of Casper interacts with caspase-3 much more and prevents its processing, yet interacts only weakly
with the protease domain of caspase-8. This is in con-avidly than does its Y360F counterpart, which has
weaker cell killing activity. trast to caspase-3, which does not interact with CrmA
under our experimental conditions (Figure 6). Previously,Although Casper(1±435) can interact with both cas-
pase-3 and caspase-8, it does not induce apoptosis. it was reported that CrmA interacts with processed cas-
pase-3 subunits (Tewari et al., 1995). Thus it is possibleInstead, it functions as a dominant negative mutant for
Fas- and TNF-induced apoptosis. This shows that the that CrmA may inhibit different caspases through differ-
ent mechanisms.simultaneous interaction of Casper with caspase-8 and
caspase-3 is not sufficient to induce apoptosis. It is When overexpressed, Casper is proteolytically pro-
cessed into two fragments. Casper deletion mutantspossible that the C-terminal fragment of Casper, which
can interact with caspase-8, may regulate the enzymatic that can induce cell death are processed, whereas the
deletion mutants that cannot induce cell death are notactivity of caspase-8 and therefore be required for Cas-
per-induced apoptosis. This model is attractive because processed. The processing site has been mapped to
Immunity
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Figure 10. Characterization of Casper Interaction with TRAF1 and TRAF2
(A) Casper interacts with TRAF1 and TRAF2, but not TRAF3. 293 cells were transfected with the Casper expression vector, together with the
indicated TRAF expression vectors. Transfected cell lysates were analyzed by immunoprecipitation (IP) with indicated antibodies and Western
blotting with a rabbit anti-Casper antibody. Positions of the molecular weight standards (in kilodaltons) are shown.
(B) The protease-like domain of Casper is sufficient to bind to TRAF1 and TRAF2. 293 cells were transfected with indicated vectors. Transfected
cell lysates were immunoprecipitated with an anti-HA antibody. Immunoprecipitating proteins were detected by Western blotting analysis
with an anti-Flag antibody. Positions of the molecular weight standards (in kilodaltons) are shown.
(C) Casper competes for the binding of c-IAP1 to TRAF2. 293 cells were transfected with 5 mg of HA-tagged TRAF2 and 5 mg of Myc-tagged
c-IAP1 vectors and an increased amount of expression vector for Casper as indicated. Transfected cell lysates were immunoprecipitated with
an anti-HA antibody. The immunoprecipitating proteins were detected by Western blotting with an anti-Myc antibody for c-IAP1. Positions of
the molecular weight standards (in kilodaltons) are shown.
A CrmA expression vector was added to the above transfection to inhibit cell death.
the D376±G377 dipeptide. Mutation of D376 to N abol- Fas through FADD, and the Casper(1±435) deletion mu-
tant can protect against Fas-induced cell death. Theseishes the processing activity but not the apoptotic activ-
ity of Casper. Since Casper processing is inhibited by findings suggest that Casper is physically and function-
ally involved in Fas signaling. Although Casper(1±435)CrmA, it is possible that Casper is processed by acti-
vated caspase-8 or caspases activated by caspase-8. also inhibits TNF-induced cell death, we have not been
able to demonstrate physical association of Casper withThese findings suggest that Casper activates a caspase
cascade, which in turn converts Casper into an inactive the TNF-R1 signaling complex. It should also be noted
that a physical association of FADD with the endoge-form.
A yeast two-hybrid screen for Casper-interacting pro- nous TNF-R1 signaling complex has yet to be demon-
strated. In mammalian overexpression systems, FADDteins yielded TRAF1 and TRAF2. Mapping experiments
demonstrated that the protease-like domain of Casper is only weakly recruited to TNF-R1 through TRADD (Hsu
et al.,1996a). Althougha direct interaction between TNF-interacts with the TRAF-N domain of TRAF1 and TRAF2.
The TRAF-N domain of TRAF1 and TRAF2 is known to R1 and FADD has been reported (Chinnaiyan et al.,
1996a), we have been unable to confirm this result (H.interact with c-IAP1 and c-IAP2 and recruit these pro-
teins to the TNF-R1 and TNF-R2 complexes (Rothe et Hsu et al., unpublished data). It is possible that a FADD-
like molecule, rather than FADD itself, may be involvedal., 1995; Shu et al., 1996). Since the c-IAPs are thought
to inhibit apoptosis, the ability of c-IAPs to compete in the TNF-R1 signaling pathway and may recruit Casper
to the TNF-R1 complex. Alternatively, it is possible thatwith Casper for TRAF1 and TRAF2 binding suggests
that the binding of TRAF1 and TRAF2 to different part- additional component(s) other than TRADD, TRAF2, and
FADD are required for recruitment of Casper to TNF-ners may regulate components associated with the TNF-
R1 and/or TNF-R2 complex, and therefore regulate cell R1. Finally, it isalso possible that Casper is not a compo-
nent of the TNF-R1 complex.death or survival.
Casper interacts with FADD and can be recruited to In conclusion, we have identified and characterized a
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(192±480) vector was performed with Chameleon site-directed mu-novel protein Casper that is related to both caspase-8
tagenesis kit (Stratagene). The other point mutation vectors usedand FADD. Casper physically interacts with FADD, cas-
in this study were made by PCR.pase-8 and caspase-3 and its overexpression induces
apoptosis. A C-terminal deletion mutant of Casper po-
Transfections
tently inhibits Fas- and TNF-R1-induced apoptosis, sug- The 293, HeLa, and HtTA-1 cell lines were maintained in high-glu-
gesting that Casper is involved in signaling pathways cose Dulbecco's modified Eagle's medium containing 10% fetal calf
leading to apoptosis. serum, 100 mg/ml penicillin G, and 100 mg/ml streptomycin (GIBCO).
For apoptosis assays, z2 3 105 cells/well were seeded on six-well
(35 mm) dishes. For coimmunoprecipitations, z2 3 106 cells/well
Experimental Procedures were seeded on 100 mm plates. Cells were transfected the following
day by the standard calcium phosphate precipitation method (Sam-
Reagents and Cell Lines brook et al., 1989).
Recombinant human TNF was provided by Genentech. The rabbit
anti-TNFR-1 and anti-Fas antisera and the monoclonal antibody
Apoptosis Assays
against the Myc epitope tag have been describedpreviously (Tartag-
b-Galactosidase cotransfection assays for determination of cell
lia et al., 1991; Wong and Goeddel, 1994; Hsu et al., 1995). The death were performed as described (Hsu et al., 1995, 1996a, 1996b).
rabbit anti-human FADD antibody was provided by V. Dixit. The Transfected cells were stained with X-gal as previously described
monoclonal antibodies against the Flag (Kodak International Bio- (Shu et al., 1995). The number of blue cells from eight viewing fields
technologies), HA (BABCO, Richmond, CA), and AU1 (BABCO) epi-
of a 35 mm dish was determined by counting. The average number
topes; the agonistic monoclonal antibody against Fas (Panvera Cor-
from one representative experiment is shown.
poration); and the monoclonal antibody against caspase-3
(Transduction Laboratory) were purchased from the indicated sup-
Yeast Two-Hybrid Screeningpliers. The human 293 embryonic kidney (R. Tjian), HeLa (Y. Jiang),
DNA encoding aa 1±215 or 192±480 of Casper was inserted intoand its derivative HtTA-1 (H. Bujard) cell lines were obtained from
the inserted in-frame into Gal4 DNA-binding domain vector pPC97the indicated sources. Rabbit polyclonal antibodies against human
(Rothe et al., 1994) or pGBT9 (Clontech). The murine fetal liver stro-Casper were raised against either a 33-mer peptide (for Casper
mal cell cDNA library (M. Rothe), human B cell cDNA library (Clon-antibody I), HRIDLKTKIQKYKQSVQGAGTSYRNVLQAAIQK, or a
tech), and human peripheral lymph node cDNA library (Clontech)35-mer peptide (for Casper antibody II), EQLGAQQEPVKKSIQESEAF
were obtained from the indicated resources. The isolationof positiveLPQSIPEE RYKMKSK, respectively (BABCO).
clones and subsequent two-hybrid interaction analyses werecarried
out as described (Rothe et al., 1994; Hsu et al., 1995, 1996a, 1996b).
cDNA Cloning
HeLa and human umbilical vein cell (HUVEC) cDNA libraries (pro- Coimmunoprecipitation and Western Analysis
vided by Z. Cao) were screened with radiolabeled probes corre- Transfected 293 cells from each 100 mm dish were lysed in 1 ml
sponding to two ESTs (GeneBank accession numbers W23795 and lysis buffer (20 mM Tris [pH 7.5], 150 mM NaCl, 1% Triton, 1 mM
T30922) following standard procedures (Sambrook et al., 1989). EDTA, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM PMSF). For
Seven independent positive clones were obtained from HeLa cDNA each immunoprecipitation, 0.8 ml aliquots of lysates were incubated
library screening and three positive clones were obtained form the with 1 ml polyclonal anti-Fas or anti-TNF-R1, or 0.5 mg monoclonal
HUVEC library screening. The cDNA inserts of the positive phage antibody against the epitope tag, and 25 ml of a 1:1 slurry of Gam-
clones were sequenced with an Applied Biosystems model 373A maBind G Plus Sepharose (Pharmacia) for at least 1 hr. The sepha-
automated DNA sequencer. rose beads were washed three times with 1 ml of lysis buffer con-
taining 500 mM NaCl. The precipitates were fractionated on
SDS±polyacrylamide gel electrophoresis (SDS-PAGE), and subse-Northern Blot Hybridization
quent Western blotting analyses were performed as described (HsuHuman multiple tissue Northern blots (Clontech) were hybridized
et al., 1995).under high-stringency conditionsusing radiolabeled Casper-encod-
ing cDNA probe according to the instructions of the manufacturer.
Assay for Protease Activity
In vitro transcription and translation was performed with the TNTMammalian Expression Vectors
SP6 Coupled Reticulocyte Lysate System (Promega) following theMammalian expression vectors encoding TNF-R1, Flag-tagged
manufacturer's recommendation. In vitro±translated 35S-labeledTRADD and FADD, Myc-tagged TRADD and RIP, CrmA, pRK5 con-
Flag-tagged caspase-3 precursor was purified by immunoprecipita-trol vector, and pCMV-b-gal have been described previously (Hsu
tion with anti-Flag antibody. The purified caspase-3 precursor waset al., 1995; Hsu et al., 1996a, 1996b). The expression vectors for
aliquoted and mixed with 10 ml of nonlabeled in vitro translationFas and AU1-tagged FADD were provided by V. Dixit. Other vectors
product or10 ml of transfected cell lysates from pRK7 control vector,used in this study were constructed by standard procedures.
pRK7-Casper (192±480), or pRK7-caspase-8 (217±479). The mixtureFull-length caspase-3 cDNA was amplified from a Jurkat cDNA
was buffered with 25 mM HEPES (pH7.5), 0.1% CHAPS, 5 mM EDTA,library and inserted into the pRK7 vector (for pRK7-caspase-3) or
and 10 mM dithiothreitol and incubated at 308C for 1.5 hr. Followingthe pRK7-Flag vector (for pRK7-Flag-caspase-3; pRK7-Flag was
incubation, the samples were subjected to SDS-PAGE and autoradi-provided by H. Song). pRK7-Myc-caspase-3 was constructed by
ography analysis.replacing the Flag epitope with the Myc epitope.
DNA encoding the Myc epitope was fused in-frame to the 59 end
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